Release Date: 19/03/19 18:12 Summary: Replacement Bidders Statement Price Sensitive: No Download Document 1.79MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%